×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NEO – neogenomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
08:05 am
neo
Court Grants Natera's Request to Include Additional Patent in its Lawsuit Against NeoGenomics [Yahoo! Finance]
Low
Report
Court Grants Natera's Request to Include Additional Patent in its Lawsuit Against NeoGenomics [Yahoo! Finance]
12/13
11:16 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Bank of America Co. from $18.00 to $19.00. They now have a "neutral" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Bank of America Co. from $18.00 to $19.00. They now have a "neutral" rating on the stock.
12/11
08:22 am
neo
NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma [Yahoo! Finance]
Low
Report
NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma [Yahoo! Finance]
12/11
08:05 am
neo
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
Low
Report
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
12/10
10:19 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock.
12/9
08:24 am
neo
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
Low
Report
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
12/9
08:10 am
neo
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
Low
Report
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
12/5
07:14 am
neo
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research [Yahoo! Finance]
Low
Report
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/10
04:09 pm
neo
Form 4 NEOGENOMICS INC For: Dec 07 Filed by: Sherman Jeffrey Scott
Low
Report
Form 4 NEOGENOMICS INC For: Dec 07 Filed by: Sherman Jeffrey Scott
12/4
04:11 pm
neo
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Olivo Alicia C
Medium
Report
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Olivo Alicia C
12/4
04:10 pm
neo
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Sherman Jeffrey Scott
Medium
Report
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Sherman Jeffrey Scott
12/4
04:09 pm
neo
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Smith Christopher M
Medium
Report
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Smith Christopher M
12/3
09:31 pm
neo
Form 4 NEOGENOMICS INC For: Dec 01 Filed by: Stone Warren
Low
Report
Form 4 NEOGENOMICS INC For: Dec 01 Filed by: Stone Warren
11/19
05:43 pm
neo
Form 4 NEOGENOMICS INC For: Nov 15 Filed by: Olivo Alicia C
Neutral
Report
Form 4 NEOGENOMICS INC For: Nov 15 Filed by: Olivo Alicia C
11/15
04:35 pm
neo
Form 144 NEOGENOMICS INC Filed by: Olivo Alicia C
Low
Report
Form 144 NEOGENOMICS INC Filed by: Olivo Alicia C
11/14
01:29 pm
neo
Form SC 13G/A NEOGENOMICS INC Filed by: T. Rowe Price Investment Management, Inc.
Low
Report
Form SC 13G/A NEOGENOMICS INC Filed by: T. Rowe Price Investment Management, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 4 NEOGENOMICS INC For: Mar 13 Filed by: JONES STEVEN C
14.5%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
TOP News Decliners
4/29
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
-13.0%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: